LeaderPortfolio
Xianfeng
Cheng Xianfeng
Rank #3376
CHINAHealthcarePharmaceuticals

Cheng Xianfeng

Net Worth
$0.987B
-2.28% (24h)
Cheng Xianfeng, born in 1968, is a Chinese billionaire and the Chairman of Yifan Pharmaceutical. His source of wealth stems from his leadership in the Pharmaceuticals industry. Yifan Pharmaceutical supplies ingredients for skin and healthcare products, and also has approvals for over 300 drugs in various therapeutic areas. His net worth, as of March 10, 2026, is approximately $959.7 million. Cheng Xianfeng's career has been marked by his role in developing Yifan Pharmaceutical into a company with research centers across China and the US.

The Full Dossier

Early Life

Details about Cheng Xianfeng's early life and education are not widely available in the public domain. However, it is known that he was born on December 1, 1968, and is a citizen of China. He is self-made.

Rise to Success

Cheng Xianfeng's rise to prominence is largely attributed to his role as the Chairman of Yifan Pharmaceutical. Yifan Pharmaceutical is a company that manufactures ingredients for skin and healthcare products, as well as feed additives. The company has approvals for over 300 drugs in areas like gynecology, pediatrics, and dermatology. The company has research centers in multiple locations including San Francisco, Shanghai, and Beijing. Cheng Xianfeng's leadership has been instrumental in the company's growth and market presence.

Key Business Strategies

Key business strategies for Yifan Pharmaceutical include product diversification, with approvals for a wide range of drugs. Cheng Xianfeng's strategic vision also includes investment in research and development, with multiple research centers. As of 2021, Cheng Xianfeng, the controlling shareholder of Yifan Pharmaceutical, pledged 15 million shares for the company's production and operation.

Philanthropy

Specific information on Cheng Xianfeng's philanthropic activities is not available in the search results.

Career Timeline

Unknown

Chairman of Yifan Pharmaceutical

Became Chairman, leading the company's growth.

Philanthropic Impact

UnknownUndisclosed

Unknown

Details of philanthropic activities are unavailable.

Wealth Trajectory